These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1092887)

  • 21. [Inhalation therapy in chronic obstructive bronchial diseases].
    Barandun J
    Schweiz Med Wochenschr; 1996 Oct; 126(40):1693-703. PubMed ID: 8966503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nebulized bronchodilators in obstructive lung disease. I.
    Sheldon GP
    Ann Allergy; 1972 Jan; 30(1):24-35. PubMed ID: 4109075
    [No Abstract]   [Full Text] [Related]  

  • 23. [Preliminary results of a trial on the spirometric and associated effects of a new bronchodilator, C 325 (author's transl)].
    Minette A; Marcq M; Bruninx M
    Acta Tuberc Pneumol Belg; 1974; 65(5):520-33. PubMed ID: 4466343
    [No Abstract]   [Full Text] [Related]  

  • 24. [The response of various indices of respiratory function to bronchodilator agents].
    Cutillo A; Omboni E; Perondi R; Tana F; Vergani D
    Atti Accad Med Lomb; 1972; 27(1-4):134-6. PubMed ID: 4681352
    [No Abstract]   [Full Text] [Related]  

  • 25. Adjunct therapy in chronic obstructive pulmonary disease.
    Lefcoe NM; Paterson NA
    Am J Med; 1973 Mar; 54(3):343-50. PubMed ID: 4569964
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results in the testing of salbutamol (Ventolin) and orciprenaline using plethysmography in patients with obstructive pulmonary diseases].
    Paulin A
    Plucne Bolesti Tuberk; 1972; 24(4):320-3. PubMed ID: 4671423
    [No Abstract]   [Full Text] [Related]  

  • 27. The combined action of broncholytic agents in asthmatic patients: orciprenaline, isoprenaline, and ephedrine.
    Muittari A; Mattila MJ; Tiitinen H
    Ann Med Intern Fenn; 1968; 57(1):31-5. PubMed ID: 4882181
    [No Abstract]   [Full Text] [Related]  

  • 28. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?].
    Musil J; Hirsch V; Vondra V; Reisová M
    Vnitr Lek; 1998 Jul; 44(7):415-7. PubMed ID: 9748878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recommendations of the German Respiratory League for treatment of patients with chronic obstructive bronchitis and pulmonary emphysema].
    Wettengel R; Böhning W; Cegla U; Criée C; Fichter J; Geisler L; Fabel H; Köhler D; Konietzko N; Lindemann H
    Med Klin (Munich); 1995 Jan; 90(1):3-7. PubMed ID: 7885301
    [No Abstract]   [Full Text] [Related]  

  • 30. [Properties of small nebulizers and their suitability for aerosol therapy].
    Wolf M; Angerstein W
    Z Erkr Atmungsorgane; 1982; 159(2):210-4. PubMed ID: 7168215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical comparison of two beta-receptor stimulants and one parasympatholytic drug in chronic obstructive lung disease.
    Kreukniet J
    Scand J Respir Dis; 1971; 52(3):137-44. PubMed ID: 4949896
    [No Abstract]   [Full Text] [Related]  

  • 32. [Inhalation therapy in chronic obstructive respiratory tract diseases. German Respiratory League].
    Pneumologie; 1994 May; 48 Suppl 1():338-41. PubMed ID: 8084879
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of respiratory insufficiency in chronic nonspecific lung diseases].
    Kazanbiev NK
    Klin Med (Mosk); 1995; 73(4):24-7. PubMed ID: 7474811
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current dosed aerosols in the treatment of obstructive airway diseases. 2. Bronchospasmolytics].
    Krecklow B
    Z Arztl Fortbild (Jena); 1984; 78(1):5-9. PubMed ID: 6231780
    [No Abstract]   [Full Text] [Related]  

  • 35. [Re: Barandun J: Inhalation therapy in chronic obstructive bronchial diseases. Schweiz Med Wochenschr 1996; 126: 1693-1703].
    Kochen MM
    Schweiz Med Wochenschr; 1997 Mar; 127(10):411. PubMed ID: 9132930
    [No Abstract]   [Full Text] [Related]  

  • 36. Nebulized bronchodilators in obstructive lung disease. II.
    Sheldon GP
    Ann Allergy; 1972 Feb; 30(2):69-85. PubMed ID: 4551435
    [No Abstract]   [Full Text] [Related]  

  • 37. Exercise-induced bronchospasm: evaluation of metaproterenol.
    Sly RM; Heimlich EM; Ginsburg J; Busser RJ; Strick L
    Ann Allergy; 1968 May; 26(5):253-8. PubMed ID: 5654963
    [No Abstract]   [Full Text] [Related]  

  • 38. [Aerosols in medicine].
    Pickroth G; Gottschalk B; Blaha H
    Z Erkr Atmungsorgane Folia Bronchol; 1973-1974; 139(2):199-222. PubMed ID: 4603326
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of stable chronic obstructive lung disease with inhaled corticosteroid].
    Vestbo J; Lange P
    Ugeskr Laeger; 2000 Jan; 162(4):520-3. PubMed ID: 10697457
    [No Abstract]   [Full Text] [Related]  

  • 40. [Aerosol therapy of patients with lung diseases].
    Kokosov AN; Potashev DA
    Klin Med (Mosk); 1988 Dec; 66(12):108-13. PubMed ID: 3230841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.